Enhancer of Zeste Homolog 2 (EZH2) Over-Expression Is Associated with Metastasis but Not with Local Tumor Characteristics nor with Mortality in Urothelial Carcinoma of the Bladder

被引：0
|
作者：
ElMansi, H. [1 ]
Aprikian, A. [1 ]
Tanguay, S. [1 ]
Bachir, B. [1 ]
Florianova, L. [1 ]
Kassouf, W. [1 ]
Brimo, F. [1 ]
机构：
[1] McGill Univ, Ctr Hlth, Montreal, PQ, Canada
来源：
LABORATORY INVESTIGATION | 2014年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
927
引用
收藏
页码：226A / 226A
页数：1
相关论文
共 50 条
  • [41] Poorly differentiated synovial sarcoma is associated with high expression of enhancer of zeste homologue 2 (EZH2)
    Changchien, Yi-Che
    Tatrai, Peter
    Papp, Gergo
    Sapi, Johanna
    Fonyad, Laszlo
    Szendroi, Miklos
    Papai, Zsuzsanna
    Sapi, Zoltan
    JOURNAL OF TRANSLATIONAL MEDICINE, 2012, 10
  • [42] Poorly differentiated synovial sarcoma is associated with high expression of enhancer of zeste homologue 2 (EZH2)
    Yi-Che Changchien
    Péter Tátrai
    Gergő Papp
    Johanna Sápi
    László Fónyad
    Miklós Szendrői
    Zsuzsanna Pápai
    Zoltán Sápi
    Journal of Translational Medicine, 10
  • [43] Overexpression of enhancer of zeste homolog 2 (EZH2), focal adhesion kinase (FAK), and pFAK in high grade endometrial carcinoma
    Semaan, A.
    Mert, I.
    Solomon, L.
    Morris, R.
    Munkarah, A.
    Sood, A.
    Ali-Fehmi, R.
    GYNECOLOGIC ONCOLOGY, 2012, 125 : S164 - S165
  • [44] Analysis of the correlation between Zeste enhancer homolog 2 (EZH2) mRNA expression and the prognosis of mesothelioma patients and immune infiltration
    Kui Fan
    Chuan-long Zhang
    Bo-hui Zhang
    Meng-qi Gao
    Yun-chuan Sun
    Scientific Reports, 12
  • [45] Enhancer of zeste-homolog 2 (EZH2) expression and clinical outcomes in metastatic castrate resistant prostate cancer (mCRPC).
    Giridhar, Karthik
    Costello, Brian Addis
    Sosa, Carlos
    Huang, Haojie
    Kohli, Manish
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [46] Positive Expression of Enhancer of Zeste Homolog 2 (EZH2) Predicts Shorter Overall Survival in Patients with Inflammatory Breast Cancer
    Gong, Y.
    Huo, L.
    Sneige, N.
    Cristofanilli, M.
    MODERN PATHOLOGY, 2010, 23 : 47A - 48A
  • [47] Analysis of the correlation between Zeste enhancer homolog 2 (EZH2) mRNA expression and the prognosis of mesothelioma patients and immune infiltration
    Fan, Kui
    Zhang, Chuan-long
    Zhang, Bo-hui
    Gao, Meng-qi
    Sun, Yun-chuan
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [48] Positive Expression of Enhancer of Zeste Homolog 2 (EZH2) Predicts Shorter Overall Survival in Patients with Inflammatory Breast Cancer
    Gong, Y.
    Huo, L.
    Sneige, N.
    Cristofanilli, M.
    LABORATORY INVESTIGATION, 2010, 90 : 47A - 48A
  • [49] Overexpression of enhancer of zeste homolog 2 (EZH2) in endometrial carcinoma: evidence from an NRG Oncology/Gynecologic Oncology Group trial
    Krill, Lauren
    Ali, Shamshad
    Eskander, Ramez
    Singh, Meenakshi
    Mutch, David
    Zweizig, Susan
    Birrer, Michael
    Lankes, Heather
    Hoang, Bang
    Randall, Leslie
    CANCER RESEARCH, 2016, 76
  • [50] Enhancer of zeste homolog 2 expression is associated with tumour cell proliferation and metastasis in gastric cancer
    Choi, J.
    Yoon, J.
    Park, B.
    Lee, Y.
    Kim, I.
    EJC SUPPLEMENTS, 2009, 7 (02): : 401 - 401
12345